Related Experiment Videos
[Second solid tumors in childhood. Review based on three cases]
I Astigarraga Aguirre1, A Navajas Gutiérrez, A Rivera Aranda
1Unidad de Oncología Infantil, Departamento de Pediatría, Hospital de Cruces de Baracaldo, Vizaya.
Anales Espanoles De Pediatria
|July 1, 1991
Summary
Longer survival for childhood cancer survivors increases second cancer risks. This study details three cases and reviews factors contributing to secondary solid tumors in pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Tumorigenesis
Background:
- Childhood cancer survival rates have improved significantly.
- This has led to an increased incidence of second malignant neoplasms (SMNs).
- Understanding SMN development is crucial for long-term pediatric cancer care.
Observation:
- Three pediatric cases of SMNs are presented.
- Cases include osteosarcoma after retinoblastoma, astrocytoma with acute lymphoblastic leukemia, and glioblastoma with neurofibromatosis and Non-Hodgkin lymphoma.
- The time intervals between initial diagnosis and SMN ranged from 2 to 12 years.
Findings:
- Genetic predisposition, immunologic factors, and therapeutic interventions are implicated in SMN development.
- Specific genetic syndromes (e.g., neurofibromatosis) and prior cancer treatments can increase risk.
- The interplay of these factors requires further investigation.
Implications:
- Improved surveillance strategies for pediatric cancer survivors are needed.
- Personalized risk assessment for SMNs should be considered.
- Further research into the mechanisms of secondary tumorigenesis can inform prevention and treatment.